vRAD selects Double Black Imaging LED displays

Westminster, CO – For Immediate Release:  vRad, a leading teleradiology service and telemedicine company with over 350 radiologists, has selected Double Black Imaging as their display provider.  Double Black Imaging develops auto-calibrating LED systems for PACS and Mammography along with their X-CAL Calibration Software suite which is written in Westminster, CO.

Deploying DBI LED systems and X-CAL throughout the vRad practice allows remote QA/QC along with ensuring compliance with DICOM, ACR, MQSA and other state-driven standards.  Double Black Imaging has guided hundreds of facilities and Radiologists licensed in NY through the requirements set forth by the State of New York for diagnostic reading.

For more information about how Double Black Imaging can assist you or your enterprise in selecting the right display system and implementing a cost effective QA/QC system, please contact us at 877-825-2870 or sales@doubleblackimaging.com.

About Double Black Imaging

Double Black Imaging develops X-Cal proprietary display system calibration software to bundle with LED systems, graphic controllers and DICOMetrix PACS Performance Monitoring Software.  DBI is dedicated to developing unique and innovative imaging solutions and components that make imaging more efficient.

About vRad

vRad (Virtual Radiologic) is the leading national teleradiology service and telemedicine company with over 350 U.S. board-certified and eligible physicians, 75% of whom are subspecialty trained. vRad is an affiliate of MEDNAX, Inc. (NYSE: MD), a national medical group specializing in neonatal, anesthesia, maternal-fetal, pediatric cardiology, and other pediatric physicians’ services. vRad interprets and processes patient imaging studies on the world’s largest and most advanced teleradiology PACS for 2,100+ client hospitals, health systems, and radiology group facilities in all 50 states. For more information, please visit www.vrad.com.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.